GL1X · GenesisL1 explorer

Research workbench

Crystal structure of mouse btk kinase domain in complex with compound 9A

Analyse Crystal structure of mouse btk kinase domain in complex with compound 9A in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6MNY
Type
protein
Length
505 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase
EC
2.7.10.2
UniProt
Q7TMU1
Ligands
JVP
Pockets
4 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase (EC 2.7.10.2)protein25243% helix, 19% strandQ7TMU1
BTyrosine-protein kinase (EC 2.7.10.2)protein25343% helix, 18% strandQ7TMU1

Ligands and binding sites

  • JVP · 5-amino-1-[(3R)-1-cyanopiperidin-3-yl]-3-[4-(2,4-difluorophenoxy)phenyl]-1H-pyrazole-4-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110830.820.8388empty
22790.700.8541JVP
3540.430.8316empty
4780.340.7517empty

Interfaces

1 interface between chains.

  • A–B · 681 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6MNY · Crystal structure of mouse BTK kinase domain in complex with compound 9a · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.